The yet-to-be-named medtech company will focus on orthopedic implants and bracing and recovery devices.
Colfax Corporation plans to split its fabrication technology and specialty medical technology businesses into two independent publicly traded companies by the first quarter of 2022.
“Our intention is to set up both companies with effective capital structures that are aligned with their different strategies,” Colfax...
Dexcom’s CEO Kevin Sayer discusses this fall’s planned launch of the 15-day G7 CGM, downplays Abbott’s dual-sensor while focusing on development of multi-analyte G8, making OTC Stelo app more “consumerish” for Europeans, and more.
“The Corsano wearable strengthens Medtronic’s acute care and monitoring portfolio,” Marc De Martini, vice president at Medtronic, told Medtech Insight.
As the EU tests the feasibility of a radical “all-in-one” procedure for combined drug and IVD studies, sponsors are being urged to approach this novel framework with flexibility and openness.
